Objectives: Aromatic diamidines have been successfully used to combat a wide range of parasites that cause important human infections. One such compound is furamidine (DB75) and we recently reported that one of its analogues, an N- phenyl analogue (DB569), exhibits higher trypanocidal dose and time-dependent effects against different forms of Trypanosoma cruzi as compared with DB75. Our present aim was to investigate the efficacy of DB569 in a T. cruzi mouse model. Methods: The trypanocidal activity of the compound was evaluated by clinical, parasitological, histopathological and biochemical investigations. Results: Treatment with DB569 significantly reduced cardiac parasitism, partially increased the survival rates of mice and lowered the levels of alanine aminotransferase and creatinine indicating a protective role against renal and hepatic lesions caused by the parasite infection. Conclusions: Altogether, the data support the potential effect of this class of compounds against T. cruzi and motivate the screening of new diamidines for efficacy against Chagas' disease. © 2006 Oxford University Press.
CITATION STYLE
de Souza, E. M., Oliveira, G. M., Boykin, D. W., Kumar, A., Hu, Q., & Soeiro, M. D. N. C. (2006). Trypanocidal activity of the phenyl-substituted analogue of furamidine DB569 against Trypanosoma cruzi infection in vivo. Journal of Antimicrobial Chemotherapy, 58(3), 610–614. https://doi.org/10.1093/jac/dkl259
Mendeley helps you to discover research relevant for your work.